Personalis (PSNL) explores potential sale after interest from Merck and others - source
Personalis (NASDAQ: PSNL) has attracted takeover interest from pharmaceutical giant Merck (NYSE: MRK) and at least two other suitors, according ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
